全文获取类型
收费全文 | 85064篇 |
免费 | 3814篇 |
国内免费 | 103篇 |
专业分类
耳鼻咽喉 | 589篇 |
儿科学 | 1897篇 |
妇产科学 | 1605篇 |
基础医学 | 7372篇 |
口腔科学 | 1393篇 |
临床医学 | 12487篇 |
内科学 | 19755篇 |
皮肤病学 | 1379篇 |
神经病学 | 7719篇 |
特种医学 | 3598篇 |
外科学 | 16767篇 |
综合类 | 326篇 |
一般理论 | 30篇 |
预防医学 | 3586篇 |
眼科学 | 1874篇 |
药学 | 2297篇 |
2篇 | |
中国医学 | 28篇 |
肿瘤学 | 6277篇 |
出版年
2023年 | 2385篇 |
2022年 | 3275篇 |
2021年 | 3778篇 |
2020年 | 3945篇 |
2019年 | 2700篇 |
2018年 | 2494篇 |
2017年 | 2500篇 |
2016年 | 2219篇 |
2015年 | 1997篇 |
2014年 | 4398篇 |
2013年 | 3838篇 |
2012年 | 3620篇 |
2011年 | 3542篇 |
2010年 | 3217篇 |
2009年 | 2904篇 |
2008年 | 3287篇 |
2007年 | 3362篇 |
2006年 | 3066篇 |
2005年 | 2854篇 |
2004年 | 2561篇 |
2003年 | 2487篇 |
2002年 | 2465篇 |
2001年 | 2253篇 |
2000年 | 2165篇 |
1999年 | 1951篇 |
1998年 | 716篇 |
1997年 | 545篇 |
1996年 | 601篇 |
1995年 | 553篇 |
1994年 | 443篇 |
1993年 | 352篇 |
1992年 | 1482篇 |
1991年 | 1335篇 |
1990年 | 1478篇 |
1989年 | 1419篇 |
1988年 | 1308篇 |
1987年 | 519篇 |
1986年 | 170篇 |
1985年 | 312篇 |
1984年 | 391篇 |
1983年 | 293篇 |
1982年 | 310篇 |
1981年 | 302篇 |
1980年 | 271篇 |
1979年 | 237篇 |
1978年 | 249篇 |
1977年 | 194篇 |
1976年 | 191篇 |
1974年 | 170篇 |
1973年 | 164篇 |
排序方式: 共有10000条查询结果,搜索用时 230 毫秒
71.
72.
《European urology》2020,77(1):e21-e22
73.
74.
75.
AimsThe effect of Origanum majorana tea consumption on motor and non-motor symptoms was investigated in patients with idiopathic Parkinson's disease, measured by validated tools.MethodsSixty patients with idiopathic Parkinson's disease and under conventional medication were enrolled voluntarily in the study. All participants were randomized on double-blind to placebo or Origanum majorana. Clinical assessment with validated tools (UPDRSIII, NMSS, and BDI) was done before Origanum majorana or placebo consumption (Day 0) and at the end of the experiment (Day 30).ResultsThe treatment groups were similar at baseline on demographic and clinical variables. During the course of study, nine participants withdrew for reasons of noncompliance and inability to follow-up. Fifty-one participants completed the study. Upon completion of 30 days of treatment, Origanum majorana tea consumption did not decrease the UPDRSIII score ([UPDRSIII] D0 = 18.76 ± 8.58, D30 = 16.52 ± 7.96, p = 0.069) at the p value was 0.07. However, a statistically significant improvement was noted in NMSS and BDI scores (p < 0.0001 and p < 0.0001, respectively). Assessment of the UPDRSIII, NMSS and BDI scores of the patients did not reflect any improvement with placebo. No side effect was detected during the study.ConclusionThese findings show improvement of depressive and non-motor signs in patients with Parkinson's disease in the group that consumed Origanum majorana tea in combination with conventional therapy. Improvement of motor signs may need an extended treatment period. However, more research with a large number of participants and lasting longer than 1 month is needed to argue these findings. 相似文献
76.
77.
78.
79.
Danielle E Whittier Elizabeth J Samelson Marian T Hannan Lauren A Burt David A Hanley Emmanuel Biver Pawel Szulc Elisabeth Sornay-Rendu Blandine Merle Roland Chapurlat Eric Lespessailles Andy Kin On Wong David Goltzman Sundeep Khosla Serge Ferrari Mary L Bouxsein Douglas P Kiel Steven K Boyd 《Journal of bone and mineral research》2022,37(3):428-439
Prevalence of osteoporosis is more than 50% in older adults, yet current clinical methods for diagnosis that rely on areal bone mineral density (aBMD) fail to detect most individuals who have a fragility fracture. Bone fragility can manifest in different forms, and a “one-size-fits-all” approach to diagnosis and management of osteoporosis may not be suitable. High-resolution peripheral quantitative computed tomography (HR-pQCT) provides additive information by capturing information about volumetric density and microarchitecture, but interpretation is challenging because of the complex interactions between the numerous properties measured. In this study, we propose that there are common combinations of bone properties, referred to as phenotypes, that are predisposed to different levels of fracture risk. Using HR-pQCT data from a multinational cohort (n = 5873, 71% female) between 40 and 96 years of age, we employed fuzzy c-means clustering, an unsupervised machine-learning method, to identify phenotypes of bone microarchitecture. Three clusters were identified, and using partial correlation analysis of HR-pQCT parameters, we characterized the clusters as low density, low volume, and healthy bone phenotypes. Most males were associated with the healthy bone phenotype, whereas females were more often associated with the low volume or low density bone phenotypes. Each phenotype had a significantly different cumulative hazard of major osteoporotic fracture (MOF) and of any incident osteoporotic fracture (p < 0.05). After adjustment for covariates (cohort, sex, and age), the low density followed by the low volume phenotype had the highest association with MOF (hazard ratio = 2.96 and 2.35, respectively), and significant associations were maintained when additionally adjusted for femoral neck aBMD (hazard ratio = 1.69 and 1.90, respectively). Further, within each phenotype, different imaging biomarkers of fracture were identified. These findings suggest that osteoporotic fracture risk is associated with bone phenotypes that capture key features of bone deterioration that are not distinguishable by aBMD. © 2021 American Society for Bone and Mineral Research (ASBMR). 相似文献
80.
《Journal of stroke and cerebrovascular diseases》2022,31(12):106808
The posterior condylar vein is an emissary vein that connects the extracranial and intracranial venous systems through the posterior condylar canal (PCC). Dural arteriovenous fistulas (DAVF) of the PCC are rare, and only seven cases have been reported. Transvenous embolization (TVE) is the first-line treatment for PCC DAVF and is predominantly performed through the internal jugular vein. Herein, we report a case of PCC DAVF treated with TVE through the deep cervical vein. This is the first case report of a PCC DAVF treated with TVE through the deep cervical vein. 相似文献